In last trading session, Cns Pharmaceuticals Inc (NASDAQ:CNSP) saw 0.5 million shares changing hands with its beta currently measuring 0.77. Company’s recent per share price level of $0.8 trading at -$0.1 or -10.71% at ring of the bell on the day assigns it a market valuation of $4.37M. That closing price of CNSP’s stock is at a discount of -7650.0% from its 52-week high price of $62.00 and is indicating a premium of 8.75% from its 52-week low price of $0.73. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.14 million shares which gives us an average trading volume of 1.71 million if we extend that period to 3-months.
Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information
Cns Pharmaceuticals Inc’s shares saw a change of -98.56% in year-to-date performance and have moved -8.55% in past 5-day. Cns Pharmaceuticals Inc (NASDAQ:CNSP) showed a performance of -3.50% in past 30-days. Number of shares sold short was 0.46 million shares which calculate 0.11 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 0.5 to the stock, which implies a fall of -60.0% to its current value. Analysts have been projecting 0.5 as a low price target for the stock while placing it at a high target of 0.5. It follows that stock’s current price would jump 37.5% in reaching the projected high whereas dropping to the targeted low would mean a gain of 37.5% for stock’s current value.
Cns Pharmaceuticals Inc (CNSP) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 70.59% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 92.28% while estimates for its earnings growth in next 5 years are of 70.98%.
Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s Major holders
Insiders are in possession of 0.21% of company’s total shares while institution are holding 1.13 percent of that, with stock having share float percentage of 1.14%. Investors also watch the number of corporate investors in a company very closely, which is 1.13% institutions for Cns Pharmaceuticals Inc that are currently holding shares of the company.
On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of May 31, 2025, the former fund manager was holding 8.5 shares of worth $6797.0 or 0.16% of the total outstanding shares. The later fund manager was in possession of 6.54 shares on May 31, 2025, making its stake of worth around $5232.0 in the company or a holder of 0.12% of company’s stock.
